Skip to content

Lars C. Wallentin

Uppsala University

3 papers in the Anchorcite directory, published between 2009 and 2011, cited 27,539 times in total.

ORCID profile

Research topics

Frequent co-authors

Papers

  1. Dabigatran versus Warfarin in Patients with Atrial FibrillationNew England Journal of Medicine · 2009 · 11,314 citations

    BACKGROUND: Warfarin reduces the risk of stroke in patients with atrial fibrillation but increases the risk of hemorrhage and is difficult to use. Dabigatran is a new oral direct thrombin inhibitor. METHODS: In this noninferiority trial, we randomly assigned 18,113…

  2. Apixaban versus Warfarin in Patients with Atrial FibrillationNew England Journal of Medicine · 2011 · 9,052 citations

    BACKGROUND: Vitamin K antagonists are highly effective in preventing stroke in patients with atrial fibrillation but have several limitations. Apixaban is a novel oral direct factor Xa inhibitor that has been shown to reduce the risk of stroke in a…

  3. Ticagrelor versus Clopidogrel in Patients with Acute Coronary SyndromesNew England Journal of Medicine · 2009 · 7,173 citations

    BACKGROUND: Ticagrelor is an oral, reversible, direct-acting inhibitor of the adenosine diphosphate receptor P2Y12 that has a more rapid onset and more pronounced platelet inhibition than clopidogrel. METHODS: In this multicenter, double-blind, randomized trial, we compared ticagrelor (180-mg loading dose,…

Metadata from OpenAlex (CC0).